Undisclosed RNA Therapeutic Program(s)

About Liferna Biotech

Liferna Biotech is a private, pre-clinical-stage biotech focused on addressing high-unmet-need autoimmune and fibrotic diseases through RNA therapeutics. The company's strategy centers on a proprietary platform technology designed for targeted drug delivery to minimize off-target effects and enhance therapeutic efficacy. With a seasoned founding team and a clear initial focus on systemic sclerosis, Liferna aims to accelerate novel treatments from the clinic to the market. The company is currently pre-revenue and in the platform validation and early pipeline development phase.

Therapeutic Areas